Affiliate disclosure: As an Amazon Associate, this site earns from qualifying purchases linked in this article.
Ready to buy? Check current prices on Amazon and compare deals before you decide.
Vaginal atrophy, now often referred to as Genitourinary Syndrome of Menopause (GSM), is a common condition that can affect women during perimenopause and menopause. It occurs due to decreased estrogen levels, which can lead to changes in the tissues of the vagina and urinary tract [1]. These changes can bring about a range of physical symptoms that may impact daily life and intimacy.
Understanding the symptoms and effects of vaginal atrophy can help women recognize when these changes are occurring and empower them to seek appropriate support. This article will explore what vaginal atrophy is, its common manifestations, and how it can affect women during the menopausal transition.
What is Vaginal Atrophy (Genitourinary Syndrome of Menopause)?
Vaginal atrophy is a term historically used to describe changes in the vaginal tissues due to reduced estrogen. More recently, the comprehensive term Genitourinary Syndrome of Menopause (GSM) was introduced to encompass a broader set of symptoms involving the vulva, vagina, and lower urinary tract, all linked to estrogen decline [2]. This decline typically happens during perimenopause and menopause, but can also occur due to other reasons for low estrogen.
Estrogen plays a vital role in maintaining the health and elasticity of vaginal tissues. When estrogen levels decrease, these tissues can become thinner, less elastic, and less lubricated [3]. This can lead to a variety of symptoms that affect not only vaginal comfort but also urinary function.
Common Vaginal Atrophy Menopause Symptoms
The symptoms associated with vaginal atrophy, or GSM, can vary in intensity and type, but many women experience one or more of the following. Vaginal dryness is a very common symptom, often leading to discomfort [4]. This dryness can make sexual activity uncomfortable or even painful, a symptom referred to as dyspareunia [1].
Other common vaginal symptoms include irritation, itching, and a burning sensation in the vulvovaginal area [1]. Some women may also notice a feeling of pressure or heaviness in the vagina. These changes can significantly impact a woman’s quality of life and sexual well-being [3].
Effects on the Urinary System
Beyond the vaginal symptoms, GSM can also affect the urinary system due to the close proximity and shared embryological origins of the genitourinary tissues. Women may experience increased urinary urgency, a frequent need to urinate, or even recurrent urinary tract infections (UTIs) [1].
Some individuals might also notice painful urination (dysuria) or stress urinary incontinence, where urine leaks during activities like coughing, sneezing, or laughing [1]. These urinary symptoms can be particularly disruptive and contribute to overall discomfort.
Impact on Sexual Health and Quality of Life
The symptoms of vaginal atrophy can have a considerable impact on a woman’s sexual health and overall quality of life. Discomfort and pain during sexual activity can lead to a reduction in libido and intimacy, potentially affecting relationships [3]. The physical changes, such as dryness and irritation, can also make everyday activities uncomfortable.
Beyond the physical aspects, living with these symptoms can sometimes lead to emotional distress, including feelings of self-consciousness or frustration [3]. Open communication with healthcare providers and partners can be helpful in navigating these challenges.
Approaches for Managing Symptoms
Several approaches are available to help manage the symptoms of vaginal atrophy and GSM. Non-hormonal options include regular use of vaginal moisturizers and lubricants. Vaginal moisturizers are designed for regular use to provide ongoing hydration to the vaginal tissues, while lubricants are used specifically during sexual activity to reduce friction and discomfort [5]. Hyaluronic acid has also been explored as a non-hormonal option for vaginal atrophy [6].
For many women, local estrogen therapy applied directly to the vagina can be a very effective way to address the underlying cause of GSM symptoms [7]. This form of estrogen therapy delivers estrogen directly to the vaginal tissues with minimal systemic absorption, helping to restore tissue health[8][4]. It comes in various forms, such as creams, rings, or tablets[5][9]. Discussing these options with a healthcare provider can help determine the most suitable approach for individual circumstances.
References
- Genitourinary Syndrome of Menopause. The Medical clinics of North America, 2023
- The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause (New York, N.Y.), 2020
- The genitourinary syndrome of menopause. Menopause (New York, N.Y.), 2021
- ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstetrics and gynecology, 2014
- Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review. Annals of internal medicine, 2024
- Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review. The journal of sexual medicine, 2021
- Management of Menopausal Symptoms: A Review. JAMA, 2023
- Hormone Therapy and Other Treatments for Symptoms of Menopause. American family physician, 2016
- The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. The Journal of urology, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
